SENATE/HOUSE FILE _____
BY (PROPOSED DEPARTMENT OF
INSPECTIONS, APPEALS, AND
LICENSING BILL)
A BILL FOR
1 An Act relating to controlled substances, including certain
2 controlled substances schedules and precursor substances
3 reporting requirements, making penalties applicable, and
4 including effective date provisions.
5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
TLSB 1405DP (3) 91
as/js

S.F. _____ H.F. _____
1 Section 1. Section 124.204, subsection 2, Code 2025, is
2 amended by adding the following new paragraphs:
3 NEW PARAGRAPH. cq. 2-methyl-N-(1-phenethylpiperidin-4-
4 yl)-N-phenylbutanamide. Other name: alpha’-Methyl butyryl
5 fentanyl.
6 NEW PARAGRAPH. cr. N-(1-(2,5-
7 dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide. Other
8 name: 2’,5’-Dimethoxyfentanyl.
9 NEW PARAGRAPH. cs. N-(1-phenethylpiperidin-4-yl)-N-
10 phenylfuran-3-carboxamide. Other name: 3-Furanyl fentanyl.
11 NEW PARAGRAPH. ct. 3-methyl-N-(1-phenethylpiperidin-4-
12 yl)-N-phenylbutanamide. Other name: Isovaleryl fentanyl.
13 NEW PARAGRAPH. cu. N-(3-fluorophenyl)-N-(1-
14 phenethylpiperidin-4-yl)propionamide. Other name: meta-
15 Fluorofentanyl.
16 NEW PARAGRAPH. cv. N-(3-fluorophenyl)-N-(1-
17 phenethylpiperidin-4-yl)isobutyramide. Other name: meta-
18 Fluoroisobutyryl fentanyl.
19 NEW PARAGRAPH. cw. N-(2-fluorophenyl)-N-(1-
20 phenethylpiperidin-4-yl)furan-2-carboxamide. Other name:
21 ortho-Fluorofuranyl fentanyl.
22 NEW PARAGRAPH. cx. N-(4-methoxyphenyl)-N-(1-
23 phenethylpiperidin-4-yl)furan-2-carboxamide. Other name:
24 para-Methoxyfuranyl fentanyl.
25 NEW PARAGRAPH. cy. N-(4-methylphenyl)-N-(1-
26 phenethylpiperidin-4-yl)cyclopropanecarboxamide. Other name:
27 para-Methylcyclopropyl fentanyl.
28 NEW PARAGRAPH. cz. 1-(2-methyl-4-(3-phenylprop-2-en-1-
29 yl)piperazin-1-yl)butan-1-one. Other name: 2-Methyl AP-237.
30 NEW PARAGRAPH. da. 2-(2-(4-ethoxybenzyl)-1H-
31 benzimidazol-1-yl)-N,N-diethylethan-1-amine. Other names:
32 etodesnitazene; etazene.
33 NEW PARAGRAPH. db. 2-(4-ethoxybenzyl)-5-nitro-1-(2-
34 (pyrrolidin-1-yl)ethyl)-1H-benzimidazole. Other names: N-
35 pyrrolidino etonitazene; etonitazepyne.
LSB 1405DP (3) 91
-1- as/js 1/6

S.F. _____ H.F. _____
1 NEW PARAGRAPH. dc. N,N-diethyl-2-(5-nitro-2-(4-
2 propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine. Other name:
3 protonitazene.
4 Sec. 2. Section 124.204, subsection 4, Code 2025, is amended
5 by adding the following new paragraphs:
6 NEW PARAGRAPH. cn. N-(1-amino-3,3-dimethyl-1-
7 oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide. Other name:
8 ADB-BUTINACA.
9 NEW PARAGRAPH. co. 4-methyl-1-phenyl-2-(pyrrolidin-1-
10 yl)pentan-1-one. Other name: alpha-PiHP.
11 NEW PARAGRAPH. cp. 2-(methylamino)-1-(3-
12 methylphenyl)propan-1-one. Other names: 3-MMC; 3-
13 methylmethcathinone.
14 Sec. 3. Section 124.204, subsection 9, Code 2025, is amended
15 by adding the following new paragraphs:
16 NEW PARAGRAPH. o. Methyl 3,3-dimethyl-2-(1-(pent-4-en-
17 1-yl)-1H-indazole-3-carboxamido)butanoate. Other name:
18 MDMB-4en-PINACA.
19 NEW PARAGRAPH. p. Methyl 2-[[1-(4-fluorobutyl)indole-
20 3-carbonyl]amino]-3,3-dimethyl-butanoate. Other names:
21 4F-MDMB-BUTICA; 4F-MDMB-BICA.
22 NEW PARAGRAPH. q. N-(1-amino-3,3-dimethyl-1-oxobutan-
23 2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide. Other
24 name: ADB-4en-PINACA.
25 NEW PARAGRAPH. r. 5-Pentyl-2-(2-phenylpropan-2-
26 yl)pyrido[4,3-b]indol-1-one. Other names: CUMYL-PEGACLONE;
27 SGT-151.
28 NEW PARAGRAPH. s. Ethyl 2-[[1-(5-fluoropentyl)indole-
29 3-carbonyl]amino]-3,3-dimethyl-butanoate. Other names:
30 5F-EDMB-PICA; 5F-EDMB-2201.
31 NEW PARAGRAPH. t. Methyl 2-(1-(4-fluorobenzyl)-1H-
32 indole-3-carboxamido)-3-methyl butanoate. Other name: MMB-
33 FUBICA.
34 NEW PARAGRAPH. u. N-ethyl-2-(2-(4-isopropoxybenzyl)-5-
35 nitro-1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters,
LSB 1405DP (3) 91
-2- as/js 2/6

S.F. _____ H.F. _____
1 ethers, salts, and salts of isomers, esters, and ethers. Other
2 name: N-desethyl isotonitazene.
3 NEW PARAGRAPH. v. 2-(4-ethoxybenzyl)-5-nitro-1-(2-
4 piperidin-1-yl)-1H-benzimidazole, its isomers, esters, ethers,
5 salts, and salts of isomers, esters, and ethers. Other names:
6 N-piperidinyl etonitazene; etonitazepipne.
7 Sec. 4. Section 124.204, subsection 9, paragraphs d, h, and
8 i, Code 2025, are amended by striking the paragraphs.
9 Sec. 5. Section 124.208, subsection 6, Code 2025, is amended
10 by adding the following new paragraphs:
11 NEW PARAGRAPH. bm. 5[alpha]-androstan-3,6,17-trione.
12 NEW PARAGRAPH. bn. 6-bromo-androsta-1,4-diene-3,17-
13 dione.
14 NEW PARAGRAPH. bo. 6-bromo-androstan-3,17-dione.
15 NEW PARAGRAPH. bp. 4-chloro-17[alpha]-methyl-androsta-
16 1,4-diene-3,17[beta]-diol.
17 NEW PARAGRAPH. bq. 4-chloro-17[alpha]-methyl-androst-
18 4-ene-3[beta],17[beta]-diol.
19 NEW PARAGRAPH. br. 4-chloro-17[alpha]-methyl-17[beta]-
20 hydroxy-androst-4-en-3-one.
21 NEW PARAGRAPH. bs. 4-chloro-17[alpha]-methyl-17[beta]-
22 hydroxy-androst-4-ene-3,11-dione.
23 NEW PARAGRAPH. bt. 2[alpha],17[alpha]-dimethyl-
24 17[beta]-hydroxy-5[beta]-androstan-3-one.
25 NEW PARAGRAPH. bu. 2[alpha],3[alpha]-epithio-
26 17[alpha]-methyl-5[alpha]-androstan-17[beta]-ol.
27 NEW PARAGRAPH. bv. estra-4,9,11-triene-3,17-dione.
28 NEW PARAGRAPH. bw. [3,2-c]furazan-5[alpha]-androstan-
29 17[beta]-ol.
30 NEW PARAGRAPH. bx. 18a-homo-3-hydroxy-estra-2,5(10)-
31 dien-17-one.
32 NEW PARAGRAPH. by. 4-hydroxy-androst-4-ene-3,17-dione.
33 NEW PARAGRAPH. bz. 17[beta]-hydroxy-androstano[2,3-
34 d]isoxazole.
35 NEW PARAGRAPH. ca. 17[beta]-hydroxy-androstano[3,2-
LSB 1405DP (3) 91
-3- as/js 3/6

S.F. _____ H.F. _____
1 c]isoxazole.
2 NEW PARAGRAPH. cb. 3[beta]-hydroxy-estra-4,9,11-trien-
3 17-one.
4 NEW PARAGRAPH. cc. 17[alpha]-methyl-androsta-1,4-
5 diene-3,17[beta]-diol.
6 NEW PARAGRAPH. cd. 17[alpha]-methyl-5[alpha]-
7 androstan-17[beta]-ol.
8 NEW PARAGRAPH. ce. 17[alpha]-methyl-androstan-3-
9 hydroxyimine-17[beta]-ol.
10 NEW PARAGRAPH. cf. 6[alpha]-methyl-androst-4-ene-3,17-
11 dione.
12 NEW PARAGRAPH. cg. 17[alpha]-methyl-androst-2-ene-
13 3,17[beta]-diol.
14 NEW PARAGRAPH. ch. [3,2-c]pyrazole-androst-4-en-
15 17[beta]-ol.
16 Sec. 6. Section 124.208, subsection 6, paragraphs a, h, v,
17 z, aa, am, ay, ba, bb, bc, bk, and bl, Code 2025, are amended
18 by striking the paragraphs and inserting in lieu thereof the
19 following:
20 a. 3[beta],17[beta]-dihydroxy-5[alpha]-androstane.
21 h. 1-androstenedione (5[alpha]-androst-1-en-3,17-dione).
22 v. Furazabol (17[alpha]-methyl-17[beta]-
23 hydroxyandrostano[2,3-c]furazan).
24 z. Mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-
25 androstan-3-one).
26 aa. Mesterolone (1[alpha]-methyl-17[beta]-hydroxy-5[alpha]-
27 androstan-3-one).
28 am. 17[alpha]-methyl-[Delta]1-dihydrotestosterone
29 (17[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one)
30 (also known as 17-[alpha]-methyl-1-testosterone).
31 ay. Oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-
32 5[alpha]-androstan-3-one).
33 ba. Oxymetholone (17[alpha]-methyl-2-hydroxymethylene-
34 17[beta]-hydroxy-5[alpha]-androstan-3-one).
35 bb. Stanozolol (17[alpha]-methyl-17[beta]-hydroxy-5[alpha]
LSB 1405DP (3) 91
-4- as/js 4/6

S.F. _____ H.F. _____
1 -androst-2-eno[3,2-c]-pyrazole).
2 bc. Stenbolone (17[beta]-hydroxy-2-methyl-5[alpha]-androst-
3 1-en-3-one).
4 bk. Methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]
5 -androstan-17[beta]-ol-3-one or 2[alpha],17[alpha]-dimethyl-
6 17[beta]-hydroxy-5[alpha]-androstan-3-one).
7 bl. Prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-
8 c]pyrazole or [3,2-c]pyrazole-5[alpha]-androstan-17[beta]-ol).
9 Sec. 7. Section 124.210, subsection 3, Code 2025, is amended
10 by adding the following new paragraph:
11 NEW PARAGRAPH. bh. Zuranolone.
12 Sec. 8. Section 124B.2, subsection 1, paragraphs y and ad,
13 Code 2025, are amended to read as follows:
14 y. Iodine in concentrations greater than 2.2 percent.
15 ad. N-phenylpiperidin-4-amine(4-anilinopiperidine;
16 N-phenyl-4-piperidinamine; 4-AP), its amides, its carbamates,
17 and its halides, its salts, and any combination thereof,
18 whenever the existence of such is possible.
19 Sec. 9. Section 124B.6, Code 2025, is amended by adding the
20 following new subsection:
21 NEW SUBSECTION. 5. A sale, transfer, furnishing, or
22 receipt of a chemical mixture identified as exempt by federal
23 regulation.
24 Sec. 10. EFFECTIVE DATE. This Act, being deemed of
25 immediate importance, takes effect upon enactment.
26 EXPLANATION
27 The inclusion of this explanation does not constitute agreement with
28 the explanation’s substance by the members of the general assembly.
29 This bill relates to controlled substances, including
30 certain controlled substances schedules and precursor
31 substances reporting requirements.
32 The bill makes changes to controlled substances schedules
33 I, III, and IV in Iowa’s uniform controlled substances Act
34 (Code chapter 124) and to the precursor substances reporting
35 requirement in Code chapter 124B to conform to the specific
LSB 1405DP (3) 91
-5- as/js 5/6

S.F. _____ H.F. _____
1 chemical designations of the substances contained in Title 21
2 of the Code of Federal Regulations, parts 1300, 1308, and 1310.
3 A violation involving a controlled substance included in the
4 bill may result in a class “B” felony, and in addition to the
5 25-year mandatory minimum term of imprisonment for class “B”
6 felons, a fine of not less than $5,000 nor more than $100,000;
7 a class “C” felony punishable by imprisonment up to 10 years
8 and a fine of not less than $1,000 nor more than $50,000; or an
9 aggravated misdemeanor punishable by imprisonment up to 2 years
10 and a fine of at least $855 but not more than $8,540.
11 The bill takes effect upon enactment.
LSB 1405DP (3) 91
-6- as/js 6/6

[DELETED: EFE_Y(DDTO,A,AGBBLFAnAtrgtocds,igccdssssadprsrgr,mgpsa,aigeedepBEITEDBYTEGLAYOFTESEOFIB1P()9]
[DELETED: .__H._Sn1.Sn1,sn2,Ce2,iadbyagtefgnwpNWP.2y.Orn:albfNWP.Nd.On:2NWP.N0p.Orn:3lf1NWP.32y.Orn:Ilf3NWP.N4p.Orn:m5F6NWP.N7p.Orn:m8Flf9NWP.N0p.Orn1olf2NWP.N3p.Orn4plf5NWP.N6p.Orn7plf8NWP.19y.Orn:2lA0NWP.21b.Orn2e;e3NWP.24(.Orn:N5poe;eB1P()9]
[DELETED: .__H._NWP.Np.OrnpS.2.Sn1,sn4,Ce2,isabyagtefgnwpNWP.No.OrnANWP.40y.Orn:a1NWP.22m.Orn:3;33m4S.3.Sn1,sn9,Ce2,isa5byagtefgnwp6NWP.Ml371.Orn8M9NWP.Ml203.Orn14;42NWP.N32.O4n:A5NWP.56y.Orn:C7S8NWP.El293.Orn05;51NWP.Ml22ilb.Orn:M3F4NWP.N5n,isi,eB1P()9]
[DELETED: .__H._e,s,adssofi,e,ade.On:NliNWP.2p,isi,e,es,adssofi,e,ade.OrnNle;eS.4.Sn1,sn9,psd,h,ai,Ce2,aeadbysgtepS.5.Sn1,sn6,Ce2,isa0byagtefgnwp1NWP.52NWP.63d4NWP.65NWP.4617NWP.4849NWP.40h1NWP.42h3NWP.2415NWP.2617NWP.e8NWP.[910NWP.11d2NWP.43NWP.14d5NWP.1B1P()9]
[DELETED: .__H._cNWP.31NWP.1dNWP.1aNWP.1h0NWP.61d2NWP.1334NWP.[516S.6.Sn1,sn6,psa,h,v7z,a,a,a,b,b,b,b,adb,Ce2,aea8bysgtepsadiginlutft9f0311e(2Fl(3h4Me(5a6Me(7a819(0(oknas11Oe(253Oe(415Sl(B1P()9]
[DELETED: .__H._-Se(1Me(-eor21Pl(ceor[S.7.Sn1,sn3,Ce2,isa0byagtefgnwp1NWP.Z2S.8.Sn1,sn1,psyada3Ce2,aeadtordasf4Ieincsgrtn22p5N6N;4,isa,isc7adish,iss,adaycnt8wrteeeofshisp9S.9.Sn1,Ce2,isadbyagt0fgnws1NWS.5.As,t,f,o2rtofaclmeidasetbyf3r4S.1.EED.TsA,bgddo5iei,tsetune6Eeinoftsendsntceatweessebytemsoftegla9Tsblrstocds,i0cncdssssadp1ssrgr2Teblmscstocdsss3I,I,adIVinIsumcdssA4(ecr1)adtoteprssr5rtinCecr1BtocmtotesB1P()9]
[DELETED: .__H._cldsoftesscdinTe2ofteCeofFlR,ps1,1,ad1Avnigacdseidintblmyrtinacs“”f,adinantot2rmymmtmofitfrcs“f,afeofntlstn$0nrmetn$acs“”fypebyitupto10yadafeofntlstn$0nrmetn$;oraadmrpebyitupto2y0adafeofatlt$5btntmetn$1TebltsetuneB1P()9]